MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
批准号:
8496607
负责人:
Mahendra Damarla
金额:
$15.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2014-06-30
关键词:
Acute Lung InjuryApoptosisApoptosis RegulatorApoptoticBlood VesselsBlood capillariesCellsComplexDataDevelopmentDiseaseEdemaEndothelial CellsEnzymesEventFunctional disorderHeat Shock Protein 27Homologous GeneHypoxiaIn VitroIncidenceInjuryInstructionLungMAP Kinase GeneMAPK14 geneMechanical StressMechanical ventilationMechanicsMediatingMediator of activation proteinMitogen-Activated Protein KinasesModelingMolecularMolecular ChaperonesMorbidity - disease rateMusPathogenesisPathway interactionsPermeabilityPhosphorylationProtein KinasePulmonary EdemaResearch PersonnelRespiratory SystemRoleSeveritiesSignal TransductionStressStretchingSupportive careSyndromeTestingTherapeuticTidal VolumeTissuesVascular PermeabilitiesVentilatorcapillarycaspase-3human MAPK14 proteinin vivoinsightinterestlung injurymortalitynew therapeutic targetnovelpressurepulmonary vascular permeabilityresponse
中文摘要
急性肺损伤(ALI)是一种发病率和死亡率都很高、治疗效果有限的毁灭性疾病。
选择。对机械通气(MV)危害的认识--支持的支柱
ALI的治疗引起了人们对参与肺血管通透性的通路越来越感兴趣
观察呼吸机相关性肺损伤(VALI)。低潮气量肺策略仍然是唯一
ALI/VALI的支持性治疗已证实有效。因此,新的疗法将专门针对
Alia/ALI中涉及屏障破坏的机制是必要的。血管内皮细胞的凋亡
最近被认为是VALI早期发病机制中的一个必要事件。此外,p38有丝分裂原
激活的蛋白(MAP)激酶是一种已知的内皮细胞凋亡的媒介,它被激活以响应
MV的损伤模式。然而,p38 MAP激酶的下游效应器参与了介导
VALI的发展和严重程度尚不清楚。P38蛋白激酶及其下游的激活
效应分子MAPK激活的蛋白激酶MK2导致小分子热休克蛋白的磷酸化
27(HSP27),已知的细胞凋亡调节因子。此外,热休克蛋白25(HSP27‘)的磷酸化对S小鼠的影响
同系物)与HVT MV介导的细胞凋亡和肺水肿相关。然而,具体的
MK2和HSP25在VALI发病中的作用机制(S)尚不清楚。这项建议
将检验MK2介导的HSP27的磷酸化对促进HVT MV至关重要的假设
使用体外机械应激模型和AN介导的细胞凋亡和由此导致的肺水肿
建立野生型和MK2-/-小鼠VALI模型。本申请的具体目标是:
1)明确MK2在体外促进机械应激诱导的细胞凋亡中的作用;2)确定MK2在促进机械应激诱导的细胞凋亡中的作用
HSP25/27在体外机械应激诱导的细胞凋亡中的磷酸化;以及3)确定HSP25/27的作用
HSP25/27磷酸化在HVT MV介导的大鼠肺血管通透性和细胞凋亡中的作用
活着。
相关性(请参阅说明):
机械通风,虽然是治疗许多疾病的基石,但有可能
加重并引起新生的肺损伤。我们已经确定了一条途径和一种潜在的机制
与机械通风引起的损伤的调解有关。我们希望进一步的洞察将有助于识别小说
治疗靶点。
英文摘要
Acute lung injury (ALI) is a devastating illness with very high morbidity and mortality and limited therapeutic
options. The recognition of the deleterious effects of mechanical ventilation (MV), the mainstay supportive
therapy for ALI, has led to increasing interest in the pathways involved in pulmonary vascular permeability
observed in ventilator-associated lung injury (VALI). Low tidal volume lung strategies remain the only
supportive treatment of ALI/VALI with proven efficacy. Therefore, novel therapies that will specifically target
mechanisms involved in barrier disruption in ALIA/ALI are needed. Endothelial cell apoptosis has been
recently implicated as a necessary event in the early pathogenesis of VALI. Additionally, the p38 mitogen
activated protein (MAP) kinase, a known mediator of endothelial cell apoptosis is activated in response to
injurious modes of MV. However, the downstream effectors of p38 MAP kinase involved in mediating the
development and severity of VALI remain unknown. Activation of p38 MAP kinase and its downstream
effector MAPK-activated protein kinase MK2 (MK2) leads to phosphorylation of the small heat shock protein
27 (HSP27), a known regulator of apoptosis. In addition, phosphorylation of HSP25 (HSP27's murine
homologue) correlates with HVT MV mediated apoptosis and pulmonary edema. However, the specific
mechanism(s) by which MK2 or HSP25 contribute to the development of VALI are unknown. This proposal
will test the hypothesis that MK2-mediated phosphorylation of HSP27 is critical for promoting HVT MV
mediated apoptosis and resultant pulmonary edema using an in vitro mechanical stress model and an
established murine model of VALI in wild type and MK2-/- mice. The specific aims of this application are to:
1) Define the role of MK2 in promoting mechanical stress-induced apoptosis in vitro; 2) Define the role of
HSP25/27 phosphorylation in mechanical stress-induced apoptosis in vitro; and 3) Determine the role for
HSP25/27 phosphorylation in HVT MV mediated apoptosis and resultant pulmonary vascular permeability in
vivo.
RELEVANCE (See instructions):
Mechanical ventilation, although the cornerstone of treatment for many disorders, has the potential to
exacerbate and cause de novo lung injury. We have identified a pathway and a potential mechanism that is
relevant in mediating injury due to mechanical ventilation. We hope that further insight will help identify novel
therapeutic targets.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.14814/phy2.13377
发表时间:
2017-08-01
期刊:
Physiological reports
影响因子:
2.5
作者:
[Damarla, Mahendra, Johnston, Laura F, Hassoun, Paul M]
通讯作者:
Hassoun, Paul M
MK2 and pulmonary hypertension
-
批准号:10491169
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2021
-
负责人:Mahendra Damarla
-
依托单位:
MK2 and pulmonary hypertension
-
批准号:10677828
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2021
-
负责人:Mahendra Damarla
-
依托单位:
MK2 and pulmonary hypertension
-
批准号:10312993
-
项目类别:
-
资助金额:$75.8万
-
财政年份:2021
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:8286945
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:7893120
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:8100257
-
项目类别:
-
资助金额:$16.22万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:7713110
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
Role of MAP Kinase Signaling in Ventilator-Associated Lung Injury
-
批准号:7485792
-
项目类别:
-
资助金额:$5.29万
-
财政年份:2007
-
负责人:Mahendra Damarla
-
依托单位:
Role of MAP Kinase Signaling in Ventilator-Associated Lung Injury
-
批准号:7332698
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2007
-
负责人:Mahendra Damarla
-
依托单位:
Short-Term Training Program to Increase Diversity in Health-Related Research
-
批准号:10578302
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2006
-
负责人:Mahendra Damarla
-
依托单位:
Short-Term Training Program to Increase Diversity in Health-Related Research
-
批准号:10065514
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2006
-
负责人:Mahendra Damarla
-
依托单位:
Short-Term Training Program to Increase Diversity in Health-Related Research
-
批准号:10306396
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2006
-
负责人:Mahendra Damarla
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: